Description of ocular alterations in patientes with Sistemic Lupus Erythematosus

Recruiting

• Conditions: Systemic Lupus Erythematosous; Ophthalmopathies; C20.111

• Registration Number: RBR-5pz9pwv
• Lead Sponsor: niversidade Federal da Bahia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-06-20
• Study Completion: 2022-12-02
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients with SLE will be recruited at the Rheumatology outpatient clinic of HUPES and must meet the inclusion criteria for SLE according to the American College of Rheumatology updated in 2019 (16). Patients over 18 years of age followed at the Hupes Rheumatology outpatient clinic will be selected

Exclusion Criteria

Exclusion criteria will be patients presenting clinical diagnosis of another rheumatologic disease; HIV; HTLV; severe Arterial Hypertention; diabetes mellitus and individuals who have other ophthalmologic pathologies not related to SLE

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To determine the prevalence of ophthalmologic alterations observed in a sample of patients with Systemic Lupus Erythematosus

Secondary Outcome Measures

Name	Time	Method
Describe the associations between ophthalmologic alterations found with clinical data and laboratory parameters of patients with lupus